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How is the recruitment of brown adipocytes regulated? Ohno et al. (2013) show that the euchromatic histone-
lysine N-metyltransferase 1 (EHMT1) is essential for the specification of the brown adipocyte fate, a finding
with important implications for the pathophysiology of obesity and obesity-related maladies.We have been blessed with several types
of adipose tissue, enabling adaptation to
cold weather and to fluctuations in the
availability of food. Whereas white adi-
pose tissue (WAT), with its richness in
energy-dense triglycerides, functions as
a buffer against fluctuations in energy
availability, brown adipose tissue (BAT)
has the capacity to uncouple mito-
chondrial respiration and produce heat.
Recent work identified a third type of
fat cell—called beige or brite—with
properties distinct from either white or
brown adipocytes (Wu et al., 2012). The
mechanisms that determine each of these
fates are still unclear. Work from Ohno
et al. (2013) examining the generation of
brown adipocytes from Myf5+ precursors
now identifies an enzymatic chromatin
switch, regulated by the histone methyl-
transferase euchromatic histone-lysine
N-metyltransferase 1 (EHMT1), as a key
factor in the development of brown
adipocytes.
More than 30 years ago, Taylor
and Jones (1979) demonstrated that
when a cell line of mesodermal origin
(3T310T1/2) was treated with 5-azacyti-
dine, a cytidine analog, the cells differen-
tiated into myocytes or adipocytes.
Thus, prevention of methylation on cyti-
dine residues by incorporation of this
nucleotide analog into the cell’s DNA
leads to activation of cellular differentia-
tion programs that result in the formation
of myocytes and adipocytes. Apart from
demonstrating the importance of epige-
netic events, these findings also sug-
gested a close interrelationship between
myocytes and adipocytes. We have since
learned that ‘‘classical’’ brown adipocytes
(and myocytes) arise from Myf5+ precur-
sor cells and form the thermogenic inter-scapular brown fat depot (Seale et al.,
2008) that is essential for the survival of
small mammals, including infants, in cold
environments (Lidell et al., 2013). This
process is mediated by the formation of
a PRDM16-C/EBPb transcriptional com-
plex that activates and maintains the
brown adipocyte gene program and,
conversely, suppresses myogenesis
(Kajimura et al., 2009). Beige adipocytes
arise from Myf5 precursor cell popula-
tions and are found interspersed within
WAT. Based on cell-autonomous differ-
ences between classical brown, beige,
and white adipocytes, Wu et al. (2012)
recently confirmed that these cells consti-
tute three distinct types of adipocytes.
Exactly how the switch fromMyf5+ pre-
cursors to brown adipocytes operates is
an open question that has recently been
addressed by Ohno et al. (2013). The
authors studied the mechanism by which
the PRDM16-C/EBPb complex acts to
induce PPARg expression, a prerequisite
for brown fat development (Kajimura
et al., 2009). Using deletion mutants of
PRDM16, Ohno et al. (2013) demonstrate
that the EHMT1 is the onlymethyltransfer-
ase that copurifies with PRDM16 com-
plexes that are capable of supporting
brown adipocyte differentiation. Ohno
et al. (2013) then show that EHMT1
is the main methyltransferase of the
PRDM16 complex in brown adipocytes
and that EHMT1 and PRDM16 act syner-
gistically to enhance PPARg transcrip-
tional activity. Ehmt1myf5 knockout mice,
lacking EHMT1 in cells derived from
Myf5+ precursors, such as classical
brown adipocytes, have less developed
interscapular brown fat, smaller brown
adipocytes, and a gene expression profile
with a broad reduction of BAT-relatedCell Metabolismgenes, findings that collectively support
a fundamental role for EHMT1 in the spec-
ification of classical brown adipocytes
versus muscle. By modulating EHMT1
levels in C2C12 myoblasts, Ohno et al.
(2013) show that EHMT1 activity is crucial
for the inhibitory effect of PRDM16 on
the myogenic gene program. EHMT1
promotes BAT formation by inducing
the epigenetic marks H3K9me2 and
H3K9me3 at promoter regions of genes
that positively regulate a myogenic gene
program, thereby repressing muscle for-
mation. This action prepares the precur-
sor cells for entering the brown adipocyte
differentiation program. Furthermore,
Ohno et al. (2013) convincingly demon-
strate that EHMT1 positively regulates
the thermogenic gene program. Finally,
mice lacking EHMT1 in cells expressing
an adiponectin-cre construct (Ehmt1adipo
knockout mice), i.e., in brown and white
adipocytes, have reduced adaptive ther-
mogenesis and display several features
of dysfunctional metabolism, such as
reduced glucose tolerance and increased
levels of liver triglycerides. Thus, EHMT1
appears to be important not only for the
formation of BAT, but also for its biolog-
ical function.
Perhaps the most interesting feature of
EHTM1 is that it provides a distinct enzy-
matic activity that, from a physiological
standpoint, has the ability to regulate the
delicate balance between muscle and
BAT formation.What are the physiological
regulators of EHTM1 activity? Will chronic
exposure to cold result in increased
EHTM1 activity, thereby promoting for-
mation of BAT? Ohno et al. (2013) provide
a clue when they show that a b3-adren-
ergic receptor agonist (CL316,243), which
mimics the physiological response to19, January 7, 2014 ª2014 Elsevier Inc. 3
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Previewscold, is less effective in inducing the for-
mation of beige adipocytes in the inguinal
WAT depot of Ehmt1adipo knockout mice
than in wild-type mice. Since Ohno et al.
(2013) mainly studied the effect of
EHMT1 on classical brown adipocytes
derived from Myf5+ precursors, it is an
open question as to whether the molecu-
lar machinery underlying this effect in
beige adipocytes is similar to that in clas-
sical brown adipocytes. Another question
relates to the bipotential precursor cells
described by Lee et al. (2012), which can
develop into either white or brown adipo-
cytes depending on the type of stimula-
tion: activation of b3-adrenergic receptor
leads to the formation of brown adipo-
cytes, while a high-fat diet stimulates the
differentiation of white adipocytes. Are
such cells derived from a population of
precursors that avoided a muscle destiny
by appropriately regulating EHTM1? One
more exciting issue is how the early B
cell factor 2 (Ebf2) relates to EHTM1.
Ebf2 also regulates PPARg activity and
acts as a key transcriptional regulator of
brown fat cell fate and function (Rajaku-
mari et al., 2013). This factor may act syn-4 Cell Metabolism 19, January 7, 2014 ª2014ergistically with EHTM1 since it recruits
PPARg to BAT-selective target genes
(Rajakumari et al., 2013), an action that
appears to be complementary to the
inhibition of muscle gene expression
mediated by EHMT1.
The recent findingsdeciphering the tran-
scriptional and chromatin code that regu-
lates brown fat formation and function are
important not only from a biological sci-
ence perspective. They also provide new
pathways and molecules that can be
tested and targeted for therapeutic pur-
poses so that the beneficial effects of hav-
ingampleamountsofbrown fat canbehar-
nessed and made available to the many
who suffer from obesity and obesity-
related maladies, such as type 2 diabetes.
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Functional brain imaging studies show that in certain brain regions glucose utilization exceeds oxygen con-
sumption, indicating the predominance of aerobic glycolysis. In this issue, Goyal et al. (2014) report that this
metabolic profile is associated with an enrichment in the expression of genes involved in synaptic plasticity
and remodeling processes.Aerobic glycolysis (AG), also known as the
Warburg effect, is a metabolic hallmark of
cancer cells (Warburg, 1956). It consists
of production of lactate from glucose in
the presence of oxygen. As it turns out,
some brain areas and cell types can also
process glucose in this way. Studies at
the whole organ level have shown already
decades ago (for Review, see AllamanandMagistretti, 2013) that glucose utiliza-
tion by the brain is in excess of oxygen
consumption by about 10%, implying a
nonoxidative use of glucose entering the
brain. Functional brain imaging studies
have identified in the adult brain areas
such as the dorsolateral prefrontal cortex,
superior and medial frontal gyrus, precu-
neus and posterior cingulate cortex, inwhich AG predominates, accounting for
25% of glucose utilization, whereas in
other areas such as the cerebellum AG
is virtually nonexistent (Vaishnavi et al.,
2010). As far as cell types are concerned,
astrocytes (glial cells) are the major sites
of AG in the brain (Be´langer et al., 2011).
The question then arises of the function
of AG in these specific locales. In an
